{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:37:32Z","timestamp":1780789052112,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ijcard.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:02:50Z","timestamp":1588719770000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: Comparison with intracoronary papaverine"],"prefix":"10.1016","volume":"314","author":[{"given":"Hidenari","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Mikuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taitou","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikuo","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Shinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.05.013_bb0005","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","article-title":"Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses","volume":"334","author":"Pijls","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jacc.2011.09.077","article-title":"Functional measurement of coronary stenosis","volume":"59","author":"Pijls","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/eurheartj\/ehs436","article-title":"Functional assessment of coronary stenoses: can we live without it?","volume":"34","author":"Pijls","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0020","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehv206","article-title":"Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments","volume":"36","author":"Berry","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0025","article-title":"ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"2019","author":"Knuuti","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/01.CIR.73.3.444","article-title":"Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans","volume":"73","author":"Wilson","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0735-1097(10)80048-8","article-title":"Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine","volume":"15","author":"Talman","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0045","first-page":"120","article-title":"Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve","volume":"39","author":"van der Voort","year":"1996","journal-title":"Catheter. Cardiovasc. Diagn."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0050","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000061950.24940.88","article-title":"Intracoronary and intravenous adenosine 5\u2032-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans","volume":"107","author":"De Bruyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0055","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.CIR.82.5.1595","article-title":"Effects of adenosine on human coronary arterial circulation","volume":"82","author":"Wilson","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0060","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0065","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0080","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2016.05.067","article-title":"Standardization of fractional flow reserve measurements","volume":"68","author":"Toth","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"91","key":"10.1016\/j.ijcard.2020.05.013_bb0090","article-title":"Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update","volume":"15","author":"Kramer","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0095","first-page":"580","article-title":"Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement","volume":"26","author":"Matsumoto","year":"2014","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0100","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2015.08.034","article-title":"Is caffeine abstention necessary before adenosine-induced fractional flow reserve measurement?","volume":"66","author":"Matsumoto","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0105","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s12350-018-1283-y","article-title":"Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation","volume":"25","author":"Dorbala","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081083","article-title":"Effects of caffeine on myocardial blood flow: a systematic review","volume":"10","author":"van Dijk","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0115","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/eurheartj\/eht040","article-title":"Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory","volume":"34","author":"Jang","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0120","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.4244\/EIJV12I2A34","article-title":"Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis","volume":"12","author":"Lee","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jjcc.2016.01.018","article-title":"Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5\u2032-triphosphate infusion","volume":"69","author":"Takami","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCINTERVENTIONS.112.968511","article-title":"Coronary pressure-derived fractional flow reserve measurements: recommendations for standardization, recording, and reporting as a core laboratory technique. Proposals for integration in clinical trials","volume":"5","author":"Vranckx","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006961","article-title":"Abnormal fractional flow reserve in nonobstructive coronary artery disease","volume":"12","author":"Imai","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0145","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2165\/00003495-200060040-00007","article-title":"Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects","volume":"60","author":"Markham","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.RES.39.1.93","article-title":"Evidence for an adenosine receptor on the surface of dog coronary myocytes","volume":"39","author":"Olsson","year":"1976","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/clpt.1989.79","article-title":"Cardiovascular effects of two xanthines and the relation to adenosine antagonism","volume":"45","author":"Smits","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0165","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jcin.2015.01.039","article-title":"Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics","volume":"8","author":"Johnson","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0170","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2012.09.065","article-title":"VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients","volume":"61","author":"Berry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MCA.0000000000000433","article-title":"Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis","volume":"28","author":"Kobayashi","year":"2017","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jjcc.2015.12.005","article-title":"Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5\u2032-triphosphate in assessment of fractional flow reserve","volume":"68","author":"Nishi","year":"2016","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.115.018747","article-title":"Significance of intermediate values of fractional flow reserve in patients with coronary artery disease","volume":"133","author":"Adjedj","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2020.05.013_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.05.013_bb0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcin.2014.02.009","article-title":"Adenosine: physiology, pharmacology, and clinical applications","volume":"7","author":"Layland","year":"2014","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320300978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320300978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:47:14Z","timestamp":1759092434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320300978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S0167527320300978"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.013","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: Comparison with intracoronary papaverine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}